TGFB1 and prostate cancer: Our data demonstrate that metformin regulates the expression of genes in additional signaling pathways known to drive the growth of prostate cancers, such as the TGF-β, Wnt, and ErbB/MAPK signaling pathways (reviewed in [55–58]).